Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PATHOS: Reduced Intensity Adjuvant Treatment in HPV+ Oropharyngeal Cancer
NCT02215265Phase 3Active, not recruiting
- Start
- Oct 2015
- Primary completion
- Oct 2027
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 3 trial of cisplatin in oropharyngeal squamous cell carcinoma (OPSCC). Started Oct 2015; status: active, not recruiting.
02
Drugs
cisplatin
03
Conditions
oropharyngeal squamous cell carcinoma (OPSCC)
Beyond the preview
Go deeper on NCT02215265.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02215265.